Heart-specific Overexpression of the Human Short CLC-3 Chloride Channel Isoform Limits Myocardial Ischemia-Induced ERP and QT Prolongation

Ying Yu,Linda Ye,Yi-Gang Li,Dean J. Burkin,Dayue Darrel Duan
DOI: https://doi.org/10.1016/j.ijcard.2016.03.191
IF: 4.039
2016-01-01
International Journal of Cardiology
Abstract:IntroductionIschemia causes myocardial infarction and arrhythmias. Up-regulation of cardiac CLC-3 chloride channels is important for ischemic preconditioning-induced second-window protection against myocardial infarction. But its consequences in ischemia-induced electrical remodeling are still unknown.MethodsThe recently-characterized heart-specific overexpression of human short CLC-3 isoform (hsCLC-3OE) mice was used to study the effects of CLC-3 up-regulation on cardiac electrophysiology under ischemia/reperfusion conditions. In vivo surface electrocardiography (ECG) and intracardiac electrophysiology (ICEP) were used to compare the electrophysiological properties of age-matched wild-type (Clcn3+/+) and hsCLC-3OE mice under control and myocardial ischemia–reperfusion conditions.ResultsQT and QTc intervals of hsCLC-3OE mice were significantly shorter than those of Clcn3+/+ mice under control, ischemia and reperfusion conditions. In the ICEP, ventricular effective refractory period (VERP) of hsCLC-3OE mice (26.7±1.7ms, n=6) was significantly shorter than that of Clcn3+/+ mice (36.9±2.8ms, n=8, P<0.05). Under ischemia condition, both VERP (19.8±1.3ms) and atrial effective refractory period (AERP, 34.8±2.5ms) of hsCLC-3OE mice were significantly shorter than those of Clcn3+/+ mice (35.2±3.0ms and 45.8±1.6ms, P<0.01, respectively). Wenckebach atrioventricular nodal block point (AVBP, 91.13±4.08ms) and 2:1 AVBP (71.3±3.8ms) of hsCLC-3OE mice were significantly shorter than those of Clcn3+/+ mice (102.0±2.0ms and 84.1±2.8ms, P<0.05, respectively). However, no differences of ICEP parameters between hsCLC-3OE and Clcn3+/+ mice were observed under reperfusion conditions.ConclusionHeart-specific overexpression of hsCLC-3 limited the ischemia-induced QT and ERP prolongation and postponed the advancements of Wenckebach and 2:1 AVBP. CLC-3 up-regulation may serve as an important adaptive mechanism against myocardial ischemia.
What problem does this paper attempt to address?